EC Number | Application | Comment | Organism |
---|---|---|---|
4.2.1.17 | medicine | ECHS1 down-regulation contributes to high-fat diet-induced hepatic steatosis | Mus musculus |
4.2.1.17 | medicine | ECHS1 down-regulation contributes to high-fat diet-induced hepatic steatosis | Homo sapiens |
4.2.1.17 | medicine | ECHS1 down-regulation contributes to high-fat diet-induced hepatic steatosis | Rattus norvegicus |
EC Number | Cloned (Comment) | Organism |
---|---|---|
2.3.1.12 | inner lipoyl domain (L2) of dihydrolipoyl acetyltransferase is expressed as a GST fusion protein | Homo sapiens |
2.3.1.122 | expressed in Escherichia coli as a His-tagged fusion protein | Mycobacterium avium |
2.3.1.122 | expressed in Escherichia coli as a His-tagged fusion protein | Mycobacterium leprae |
2.3.1.136 | expressed in Escherichia coli as a C-terminal hexahistidine tagged fusion protein | Neisseria meningitidis |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
2.3.1.122 | L130S | leucine at position 130 of Mycobacterium leprae FbpA limits access of mycolate-containing glycolipid substrates to their binding site. Mutant L130S exhibits an enhanced mycosyltransferase activity compared to wild-type while the ability to transfer the unbranched acyl chain is unchanged. Km (substrate: short-chain trehalose monomycolate): 0.043 mM, sharply decreased compared to wild-type | Mycobacterium leprae |
2.3.1.122 | S130L | mutant S130L of Mycobacterium avium exhibits a reduced mycosyltransferase activity compared to wild-type | Mycobacterium avium |
2.3.1.136 | D359A | mutant shows enzymatic activity comparable to wild-type | Neisseria meningitidis |
2.3.1.136 | D371A | mutant shows enzymatic activity comparable to wild-type | Neisseria meningitidis |
2.3.1.136 | D376A | mutant shows no enzymatic activity | Neisseria meningitidis |
2.3.1.136 | DELTA1-103 | mutant lacking the first 103 amino acids: after purification mutant is found as a monomer, indicating that dimerization of OatC depends on the first 34 amino acids. Mutant shows no activity | Neisseria meningitidis |
2.3.1.136 | DELTA1-34 | mutant lacking the first 34 amino acids: after purification mutant is found as a monomer, indicating that dimerization of OatC depends on the first 34 amino acids. Mutant retains 25% activity | Neisseria meningitidis |
2.3.1.136 | E336A | mutant shows enzymatic activity comparable to wild-type | Neisseria meningitidis |
2.3.1.136 | E345A | mutant shows enzymatic activity comparable to wild-type | Neisseria meningitidis |
2.3.1.136 | E379A | mutant shows enzymatic activity comparable to wild-type | Neisseria meningitidis |
2.3.1.136 | H111A | mutant shows enzymatic activity comparable to wild-type | Neisseria meningitidis |
2.3.1.136 | H183A | mutant shows enzymatic activity comparable to wild-type | Neisseria meningitidis |
2.3.1.136 | H267A | mutant shows enzymatic activity comparable to wild-type | Neisseria meningitidis |
2.3.1.136 | H31A | mutant shows enzymatic activity comparable to wild-type | Neisseria meningitidis |
2.3.1.136 | H399A | mutant shows no enzymatic activity | Neisseria meningitidis |
2.3.1.136 | H456A | mutant shows reduced enzymatic activity, 70% of wild-type level | Neisseria meningitidis |
2.3.1.136 | S285A | mutant retains 80% of wild-type activity | Neisseria meningitidis |
2.3.1.136 | S286A | mutant shows no enzymatic activity | Neisseria meningitidis |
2.3.1.136 | S286C | mutant shows no enzymatic activity | Neisseria meningitidis |
2.5.1.15 | P57S | the prevalence of DHPS mutations in Pneumocystis jirovecii strains isolated from South African Pneumocystis jirovecii pneumonia patients are examined. Mutations resulting in amino-acid substitutions Thr55Ala and/or Pro57Ser are detected in Pneumocystis jirovecii from 85/151 (56%) patients. The high frequency of PCP episodes with Pneumocystis jirovecii harbouring DHPS mutations in South Africa indicates that populations of this fungus are evolving under considerable selective pressure exerted by sulfa-containing antibiotics | Pneumocystis jirovecii |
2.5.1.15 | T55A | the prevalence of DHPS mutations in Pneumocystis jirovecii strains isolated from South African Pneumocystis jirovecii pneumonia patients are examined. Mutations resulting in amino-acid substitutions Thr55Ala and/or Pro57Ser are detected in Pneumocystis jirovecii from 85/151 (56%) patients. The high frequency of PCP episodes with Pneumocystis jirovecii harbouring DHPS mutations in South Africa indicates that populations of this fungus are evolving under considerable selective pressure exerted by sulfa-containing antibiotics | Pneumocystis jirovecii |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
2.3.1.122 | 0.043 | - |
alpha,alpha-trehalose 6-monomycolate | mutant L130S, short-chain trehalose monomycolate is used as a substrate, Vmax: 4.27 nmol/min/nmol | Mycobacterium leprae | |
2.3.1.122 | 0.459 | - |
alpha,alpha-trehalose 6-monomycolate | wild-type, short-chain trehalose monomycolate is used as a substrate, Vmax: 3.83 nmol/min/nmol | Mycobacterium leprae |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
2.3.1.12 | K+ | association of the pyruvate dehydrogenase kinase2 and GST-L2 (glutathione-S-transferase fused to the inner lipoyl domain (L2) of dihydrolipoyl acetyltransferase (E2)) dimers is enhanced by K+ | Homo sapiens | |
2.3.1.12 | phosphate | phosphate has a pronounced effect in increasing ligand interference with pyruvate dehydrogenase kinase2 and GST-L2 (glutathione-S-transferase fused to the inner lipoyl domain (L2) of dihydrolipoyl acetyltransferase (E2)) | Homo sapiens |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
2.3.1.136 | 54000 | - |
SDS-PAGE, the first 34 amino acids form an efficient oligomerization domain, 2 * 54000 Da | Neisseria meningitidis |
2.3.1.136 | 54300 | - |
SDS-PAGE | Neisseria meningitidis |
2.3.1.136 | 105000 | - |
gel filtration | Neisseria meningitidis |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.3.1.12 | Homo sapiens | - |
- |
- |
2.3.1.15 | Mus musculus | - |
- |
- |
2.3.1.122 | Mycobacterium avium | - |
- |
- |
2.3.1.122 | Mycobacterium leprae | - |
- |
- |
2.3.1.136 | Neisseria meningitidis | - |
- |
- |
2.5.1.15 | Pneumocystis jirovecii | - |
- |
- |
4.2.1.17 | Homo sapiens | - |
- |
- |
4.2.1.17 | Mus musculus | - |
- |
- |
4.2.1.17 | Rattus norvegicus | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
2.3.1.122 | using Ni-NTA chromatography | Mycobacterium avium |
2.3.1.122 | using Ni-NTA chromatography | Mycobacterium leprae |
2.3.1.136 | using a HisTrap HP column and a a Superdex 200 HR 10/30 column. FInal yield: 24 mg of enzyme from 500 ml of bacterial culture | Neisseria meningitidis |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
4.2.1.17 | AML-12 cell | - |
Mus musculus | - |
4.2.1.17 | liver | - |
Mus musculus | - |
4.2.1.17 | liver | - |
Homo sapiens | - |
4.2.1.17 | liver | - |
Rattus norvegicus | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
2.3.1.122 | additional information | - |
compared to FbpA of Mycobacterium leprae activity of FbpA is strikingly enhanced in Mycobacterium avium | Mycobacterium avium |
2.3.1.122 | additional information | - |
compared to FbpA of Mycobacterium tuberculosis and Mycobacterium avium activity of FbpA is reduced in Mycobacterium leprae | Mycobacterium leprae |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.122 | 2 alpha,alpha-trehalose 6-monomycolate | - |
Mycobacterium avium | alpha,alpha-trehalose 6,6'-dimycolate + alpha,alpha-trehalose | - |
? | |
2.3.1.122 | 2 alpha,alpha-trehalose 6-monomycolate | substrate contains alpha-branched long-chain fatty acids. Only tiny amounts of trehalose dimycolate are detected. It is shown that FbpA mycolyltransferase from Mycobacterium leprae retains the ability to transfer unbranched but not alpha-branched fatty acids | Mycobacterium leprae | alpha,alpha-trehalose 6,6'-dimycolate + alpha,alpha-trehalose | - |
? | |
2.3.1.122 | alpha,alpha-trehalose monomycolate + D-glucose | D-glucose is used as an alternative acceptor substrate. FbpA mycolyltransferase from Mycobacterium leprae shows only trace of glucose monomycolate is detected | Mycobacterium leprae | D-glucose monomycolate + alpha,alpha-trehalose | - |
? | |
2.3.1.122 | alpha,alpha-trehalose monomycolate + D-glucose | Mycobacterium tuberculosis and Mycobacterium avium, replace TDM with glucose monomycolate by borrowing host-derived glucose as an alternative substrate for the FbpA mycolyltransferase | Mycobacterium avium | D-glucose monomycolate + alpha,alpha-trehalose | - |
? | |
2.3.1.136 | additional information | no enzymatic activity is detected for free Neu5Ac and CMP-Neu5Ac, indicating that OatC is specific for oligo- or polySia. Since only Neisseria meningitidis serogroup C capsular polysaccharide (NmC-CPS) serves as an acceptor, this demonstrates that OatC is highly specific for alpha2,9-linked polySia | Neisseria meningitidis | ? | - |
? | |
2.3.1.136 | Neisseria meningitidis serogroup C capsular polysaccharide + acetyl-CoA | relative activity: 100% | Neisseria meningitidis | ? | - |
? | |
2.3.1.136 | Neisseria meningitidis serogroup C capsular polysaccharide + propionyl-CoA | relative activity: 21.4% | Neisseria meningitidis | ? | - |
? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
2.3.1.12 | dimer | GST-L2, glutathione-S-transferase fused to the inner lipoyl domain (L2) of dihydrolipoyl acetyltransferase exists as a dimer | Homo sapiens |
2.3.1.136 | homodimer | SDS-PAGE, the first 34 amino acids form an efficient oligomerization domain, 2 * 54000 Da | Neisseria meningitidis |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.3.1.12 | dihydrolipoyl acetyltransferase | glutathione-S-transferase fused to the inner lipoyl domain is used | Homo sapiens |
2.3.1.15 | glycerol-3-phosphate acyltransferase-1 | - |
Mus musculus |
2.3.1.15 | GPAT-1 | - |
Mus musculus |
2.3.1.122 | FbpA mycolyltransferase | - |
Mycobacterium avium |
2.3.1.122 | FbpA mycolyltransferase | - |
Mycobacterium leprae |
2.3.1.136 | OatC | - |
Neisseria meningitidis |
2.3.1.136 | polysialic-acid O-acetyltransferase | - |
Neisseria meningitidis |
2.5.1.15 | DHPS | - |
Pneumocystis jirovecii |
2.5.1.15 | dihydropteroate synthase | - |
Pneumocystis jirovecii |
4.2.1.17 | ECHS1 | - |
Mus musculus |
4.2.1.17 | ECHS1 | - |
Homo sapiens |
4.2.1.17 | ECHS1 | - |
Rattus norvegicus |
4.2.1.17 | enoyl-CoA hydratase | - |
Mus musculus |
4.2.1.17 | enoyl-CoA hydratase | - |
Homo sapiens |
4.2.1.17 | enoyl-CoA hydratase | - |
Rattus norvegicus |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
2.3.1.122 | 37 | - |
assay at | Mycobacterium avium |
2.3.1.122 | 37 | - |
assay at | Mycobacterium leprae |
2.3.1.136 | 25 | - |
assay at | Neisseria meningitidis |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
2.3.1.122 | 7.5 | - |
assay at | Mycobacterium avium |
2.3.1.122 | 7.5 | - |
assay at | Mycobacterium leprae |
2.3.1.136 | 7.5 | - |
assay at | Neisseria meningitidis |
EC Number | Organism | Comment | Expression |
---|---|---|---|
4.2.1.17 | Rattus norvegicus | a proteomic approach is applied to examine the effect of high fat diet on the liver proteome during the progression of nonalcoholic fatty liver disease. Male rats fed an high-fat diet for 4, 12, and 24 weeks show a reduced protein level of ECHS1 | down |
4.2.1.17 | Homo sapiens | ECHS1 expression level in patients with simple steatosis is reduced | down |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.3.1.12 | malfunction | Nov3r a lipoyl group-binding site inhibitor (related trifluoro-2-hydroxy-2-menthylpropionate compound) prevents pyruvate dehydrogenase kinase2 and GST-L2 (glutathione-S-transferase fused to the inner lipoyl domain (L2) of dihydrolipoyl acetyltransferase) binding and dissect the effects of Nov3r binding at the lipoyl group binding site on PDHK2 binding of other ligands | Homo sapiens |
2.3.1.15 | malfunction | T-lymphocyte proliferation is inhibited and activation induced apoptosis is increased in GPAT-1 knockout mice. Th-1 (IL-2 and IFN-gamma) cytokine secretion is reduced, and Th-2 (IL-4 and IL-10) cytokine secretion is increased. An increased arachidonate content and subsequent increased prostaglandin E2 secretion is shown in knockout mice, which may inhibit T-lymphocyte proliferation | Mus musculus |
2.5.1.15 | physiological function | the prevalence of DHPS mutations in Pneumocystis jirovecii strains isolated from South African Pneumocystis jirovecii pneumonia patients are examined. Mutations resulting in amino-acid substitutions Thr55Ala and/or Pro57Ser are detected in Pneumocystis jirovecii from 85/151 (56%) patients. The high frequency of PCP episodes with Pneumocystis jirovecii harbouring DHPS mutations in South Africa indicates that populations of this fungus are evolving under considerable selective pressure exerted by sulfa-containing antibiotics | Pneumocystis jirovecii |
4.2.1.17 | malfunction | siRNA-mediated knockdown of ECHS1 in the murine hepatocyte cell line alpha mouse liver 12 demonstrate increased cellular lipid accumulation induced by free fatty acid overload. Administering ECHS1 siRNA specifically reduces the expression of ECHS1 protein in mice liver, which significantly exacerbates the hepatic steatosis induced by an high fat diet | Mus musculus |